Facebook
Twitter
LinkedIn
ForwardDepartment of Plastic Surgery 21st Annual Research Day
Target Audience
The target audience for this meeting includes, but it is not limited to, plastic surgeons in practice and in training both private and academic and members of the plastic surgery research community.
Learning Objectives
Demonstrate knowledge of current concepts in plastic and reconstructive surgery.
Access clinical data that will have a direct impact on the everyday practice of plastic surgery.
Integrate basic science research to assist in making better clinical and operative decisions.
Implement techniques in the areas of patient safety, clinical/surgical outcomes, and complications that will improve their performance and patient outcomes.
Additional Information
| Attachment | Size |
|---|---|
 DOPS_ResearchDay2024_Program_FINAL.pdf | 536.46 KB |
7:00 AM – 7:30 AM | Breakfast |
7:30 AM – 7:45 AM | Introduction and Opening Remarks – Dr. J. Peter Rubin |
7:45 AM – 8:45 AM
| Benjamin Levi, MD Visiting Professor Dr. Lee Hudson-Robert R. Penn Chair Division Chief of General Surgery Director, Center for Organogenesis Regeneration & Trauma Associate Professor in Surgery, University of Texas Southwestern Medical Center “From Forest Fires to the Front Lines: Advances in Burn Care and Reconstruction” |
8:45 AM – 9:00 AM | Break/Vendor Exhibits |
9:00 AM – 10:30 AM | Session I – Clinical Research I Presentations |
10:30 AM – 10:45 AM | Break/Vendor Exhibits |
10:45 AM – 12:00 PM | Session II – Education, Quality and Innovation Presentations |
12:00 PM – 1:00 PM | Benjamin Levi, MD Visiting Professor Dr. Lee Hudson-Robert R. Penn Chair Division Chief of General Surgery Director, Center for Organogenesis Regeneration & Trauma Associate Professor in Surgery, University of Texas Southwestern Medical Center “How Musculoskeletal Tissues Turn to Steel and Leveraging this to Enhance Regeneration in the Steel City” |
1:00 PM – 2:30 PM | Session III – Clinical Research II Presentations |
2:30 PM – 2:45 PM | Break/Vendor Exhibits |
2:45 PM – 3:25 PM | Session IV – Basic Science Presentations |
3:25 PM – 3:30 PM | Concluding Remarks – Dr. Jesse Goldstein and Dr. Kacey Marra |
3:30 PM | Adjournment |
3:30 PM – 5:30 PM | Reception and Award Presentations |
Faculty Disclosures All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for the individuals listed below have been mitigated.
Dana Bregman: Consultant with Balmoral Medical LLC.
Gayle Gordillo: Stockholder (Privately Held) with Med Compliance LLC.
Jeffrey Gusenoff: CEO: Push2Spin Technologies Inc.; Co-CEO: BRRG Innovations LLC.; Royalties Springer Publishing.
Murali Kuvuur: Stockholder (Publicly Traded) with Novo Nordisk.
Benjamin Levi: Grant/Research Support with NIH, DOD, and Regeneron; Consultant: Ashibio.
Joseph Losee: Other with Elseiver and Thiemee.
Ernest Manders: Stockholder (Privately Held)with Proemthean LifeSciences Inc., Corps of Discovery Ventures LLC, and Undaunted Bio, Inc.
Kacey Marra: Grant/Research Support with DOD/NIH and Smith and Nephew.
Andrea Moreira: Consultant: RTI and Axogen.
David Ring: Grant/Research Support with NIH; Consultant: Everus; Stockholder (Privately Held): MyMedicalHub; Royalties: Skeletal Dynamics and Wolter-Kleuwer.
Peter Rubin: Consultant with Sofregen, Regen Med LLC, and Plastic Surgery Channel.
Teun Teunis: Grant/Research Support with Integra.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 6.50 AAPA Category I CME
- 6.50 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 6.50 Attendance
Thank you to our exhibitors:
Acera Surgical
Allergan Aesthetics
BD
DePuy Synthes
Integra LifeSciences
Kerecis
KLS Martin
Mentor Worldwide, LLC
Mitaka USA
MTF Biologics
PolyNovo NorthAmerica
RTI Surgical